Get the Stockscreener App
1.04
33.13%
0.2588
After Hours:
.99
-0.05
-4.81%
Femasys Inc stock is traded at $1.04, with a volume of 14.89M.
It is up +33.13% in the last 24 hours and up +39.19% over the past month.
Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.
See More
Previous Close:
$0.7812
Open:
$0.78
24h Volume:
14.89M
Relative Volume:
2.03
Market Cap:
$33.88M
Revenue:
$950.10K
Net Income/Loss:
$-16.69M
P/E Ratio:
-1.253
EPS:
-0.83
Net Cash Flow:
$-15.16M
1W Performance:
+63.24%
1M Performance:
+39.19%
6M Performance:
-8.77%
1Y Performance:
-7.96%
1-Day Range:
$0.78
$1.05
1-Week Range:
$0.61
$1.05
52-Week Range:
$0.3067
$1.80
Femasys Inc Stock (FEMY) Company Profile
Name
Femasys Inc
Sector
Industry
Phone
770-500-3910
Address
3950 JOHNS CREEK COURT, SUWANEE
Compare FEMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FEMY
Femasys Inc
|
1.04 | 33.60M | 950.10K | -16.69M | -15.16M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
560.00 | 194.19B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
177.84 | 50.84B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
251.49 | 36.44B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
ALC
Alcon Inc
|
73.97 | 36.72B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
271.04 | 19.81B | 2.96B | 487.70M | 344.00M | 6.6758 |
Femasys Inc Stock (FEMY) Latest News
Femasys Inc expected to post a loss of 13 cents a shareEarnings Preview - TradingView
Femasys Secures $12 Million Through Private Placement - TipRanks
[8-K] FEMASYS INC Reports Material Event | FEMY SEC FilingForm 8-K - Stock Titan
Femasys gets FDA OK for final FemBloc trial, secures $12M financing, stock surges - MSN
Why Femasys Inc. stock is considered a top pick2025 Market Sentiment & Safe Entry Zone Tips - newser.com
Combining machine learning predictions for Femasys Inc.Market Rally & Weekly Market Pulse Updates - newser.com
Can Femasys Inc. stock reach $100 price targetEarnings Growth Summary & Growth-Oriented Investment Plans - newser.com
Is Femasys Inc. stock a safe haven assetEarnings Beat & AI Enhanced Trading Signals - newser.com
Is Femasys Inc. stock affected by interest rate hikesMarket Risk Summary & Daily Market Momentum Tracking - newser.com
What Wall Street predicts for Femasys Inc. stock price2025 Trade Ideas & Low Drawdown Trading Strategies - newser.com
Applying Wyckoff theory to Femasys Inc. stockJuly 2025 Pullbacks & Low Volatility Stock Suggestions - newser.com
Is Femasys Inc. trending in predictive chart modelsRate Hike & Verified Chart Pattern Signals - newser.com
Will Femasys Inc. stock continue upward momentumQuarterly Market Review & Community Consensus Trade Signals - newser.com
How resilient is Femasys Inc. stock in market downturns2025 Buyback Activity & Safe Capital Investment Plans - fcp.pa.gov.br
Applying Elliott Wave Theory to Femasys Inc.Take Profit & Fast Momentum Entry Tips - newser.com
Does Femasys Inc. show high probability of reboundJuly 2025 EndofMonth & Fast Entry High Yield Stock Tips - newser.com
How analysts rate Femasys Inc. stock todayJuly 2025 Trade Ideas & Verified Short-Term Plans - fcp.pa.gov.br
Exit strategy if you’re trapped in Femasys Inc.Weekly Loss Report & Consistent Return Strategy Ideas - newser.com
Is Femasys Inc. forming a bottoming baseQuarterly Growth Report & Expert Curated Trade Setups - newser.com
MSN Money - MSN
Femasys secures FDA approval to advance final FemBloc trial phase - MSN
Will Femasys Inc. stock benefit from commodity pricesEarnings Growth Report & Stepwise Entry/Exit Trade Alerts - newser.com
What margin trends mean for Femasys Inc. stockTrade Ideas & High Accuracy Swing Entry Alerts - newser.com
What to do if you’re stuck in Femasys Inc.2025 Investor Takeaways & Weekly High Return Stock Opportunities - newser.com
FDA approves Femasys to continue pivotal trial for non-surgical birth control - Investing.com Australia
Femasys Stock Sparks Retail Frenzy After FDA Clears Final Phase Of FemBloc Trial And $58M Financing - MSN
Femasys surges on Fembloc FDA approval, $58 million funding news | Tap to know more | Inshorts - Inshorts
Femasys Secures Fda Approval to Advance Final Fembloc Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - MarketScreener
Femasys Inc. announced that it expects to receive $12 million in funding - MarketScreener
Femasys (FEMY) Skyrockets on Breakthrough Birth Control Trial News – Is This Women’s Health Innovator a Game-Changer? - ts2.tech
Femasys Receives FDA Approval for FemBloc Trial - TipRanks
Femasys Inc Secures FDA Approval for Final FemBloc Trial Phase - TradingView
Femasys Inc. Advances FemBloc Toward FDA Approval with Successful Trial Completion and $12 Million Financing - Quiver Quantitative
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, with Potential to Reach $58 Million - The Manila Times
Femasys Secures FDA Approval to Advance Final FemBloc® Trial Phase and $12 Million Financing, ... - Caledonian Record
Femasys (NASDAQ: FEMY) to issue $12M notes; warrants lift total potential to $58M - Stock Titan
Femasys Meets Nasdaq Equity Requirement After Offering - MSN
Custom watchlist performance reports with Femasys Inc.Earnings Overview Summary & Accurate Buy Signal Notifications - newser.com
Femasys Inc Stock (FEMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.11%
0.07%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):